Plasmalogen Production via Concentration and Refrigerated Standing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing plasmalogen on an industrial scale result in significant reduction of obtainable plasmalogen when the alcohol extract of plasmalogen-containing animal tissue is allowed to stand at normal temperature.
Innovation Solution
Concentrating an alcohol extract of plasmalogen-containing animal tissue and then diluting the concentrate, followed by allowing it to stand under refrigeration at 2 to 15°C for 1 to 7 days, rather than at normal temperature.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of time
If the alcohol extract of plasmalogen-containing animal tissue is allowed to stand at normal temperature, then the production process is simple and fast, but the amount of obtainable plasmalogen is significantly reduced
Solution Approach 1:
The patent changes the temperature parameter from normal temperature to refrigeration temperature (2 to 15°C) during the standing period. This parameter change prevents the significant reduction of plasmalogen content while maintaining the extraction process efficiency, thereby resolving the contradiction between processing time and substance loss.
2Ease of operation
If the alcohol extract is concentrated and diluted at normal temperature, then the operation is convenient, but plasmalogen content is significantly reduced
Solution Approach 1:
The patent applies temperature parameter change by conducting concentration and dilution operations under refrigeration (2 to 15°C) instead of at normal temperature. This maintains higher plasmalogen content while the refrigeration equipment provides sufficient operational convenience for industrial production.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method prevents significant reduction of plasmalogen content, enabling the production of a composition containing plasmalogen derived from animal tissue without loss, thereby maintaining higher plasmalogen levels.
Implementation Method 1
concentrating an alcohol extract of a plasmalogen-containing animal tissue
Implementation Method 2
concentrating an alcohol extract of a plasmalogen-containing animal tissue
Implementation Method 3
after diluting a concentrated product obtained by (A)
Implementation Method 4
allowing to stand under refrigeration
Data Source
AI summary
Provided is a method for producing a composition containing plasmalogen derived from a plasmalogen-containing animal tissue, the method being without significantly decreasing an amount of plasmalogen derived the plasmalogen-containing animal tissue. A method for producing a composition containing plasmalogen derived from an animal tissue, the method comprising: (A) concentrating an alcohol extract of a plasmalogen-containing animal tissue, and (B) after diluting a concentrated product obtained by (A), allowing to stand under refrigeration.
